Unknown

Dataset Information

0

Tissue-specific pathways for estrogen regulation of ovarian cancer growth and metastasis.


ABSTRACT: Menopausal estrogen (E2) replacement therapy increases the risk of estrogen receptor (ER)-positive epithelial ovarian cancers (EOC). Whether E2 is tumorigenic or promotes expansion of undiagnosed preexisting disease is unknown. To determine E2 effects on tumor promotion, we developed an intraperitoneal mouse xenograft model using ZsGreen fluorescent ER(-) 2008 and ER(+) PEO4 human EOC cells. Tumor growth was quantified by in vivo fluorescent imaging. In ER(+) tumors, E2 significantly increased size, induced progesterone receptors, and promoted lymph node metastasis, confirming that ERs are functional and foster aggressiveness. Laser-captured human EOC cells from ER(-) and ER(+) xenografted tumors were profiled for expression of E2-regulated genes. Three classes of E2-regulated EOC genes were defined, but <10% were shared with E2-regulated breast cancer genes. Because breast cancer selective ER modulators (SERM) are therapeutically ineffective in EOC, we suggest that our EOC-specific E2-regulated genes can assist pharmacologic discovery of ovarian-targeted SERM.

SUBMITTER: Spillman MA 

PROVIDER: S-EPMC3804411 | biostudies-literature | 2010 Nov

REPOSITORIES: biostudies-literature

altmetric image

Publications

Tissue-specific pathways for estrogen regulation of ovarian cancer growth and metastasis.

Spillman Monique A MA   Manning Nicole G NG   Dye Wendy W WW   Sartorius Carol A CA   Post Miriam D MD   Harrell Joshua Chuck JC   Jacobsen Britta M BM   Horwitz Kathryn B KB  

Cancer research 20101019 21


Menopausal estrogen (E2) replacement therapy increases the risk of estrogen receptor (ER)-positive epithelial ovarian cancers (EOC). Whether E2 is tumorigenic or promotes expansion of undiagnosed preexisting disease is unknown. To determine E2 effects on tumor promotion, we developed an intraperitoneal mouse xenograft model using ZsGreen fluorescent ER(-) 2008 and ER(+) PEO4 human EOC cells. Tumor growth was quantified by in vivo fluorescent imaging. In ER(+) tumors, E2 significantly increased s  ...[more]

Similar Datasets

| S-ECPF-GEOD-22600 | biostudies-other
2011-05-13 | E-GEOD-22600 | biostudies-arrayexpress
2011-05-13 | GSE22600 | GEO
| S-EPMC6546519 | biostudies-literature
| S-EPMC8195659 | biostudies-literature
| S-EPMC7821038 | biostudies-literature
| S-EPMC8245162 | biostudies-literature
| S-EPMC9110888 | biostudies-literature
| S-EPMC6317723 | biostudies-literature
| S-EPMC3731129 | biostudies-literature